EMR vs REGN · P/E 34, rev $4.86B vs P/E 14, rev $4.29B
Emerson Electric Company (EMR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the EMR and REGN stock pages for the full models.
Not investment advice.